A Reconsideration of the Relevance of Systemic Low-Dose Ketamine to the Pathophysiology of Fibromyalgia

Journal of Pain

Volumn 7, Issue 9, 2006, Pages 611-614

  Wood, Patrick B ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

central sensitization; dopamine; Fibromyalgia; ketamine; n methyl d aspartate receptor

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PRAMIPEXOLE; RECEPTOR SUBTYPE;

ANALGESIC ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CINGULATE GYRUS; CLINICAL TRIAL; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; FIBROMYALGIA; HUMAN; INSULA; LIMBIC SYSTEM; LOW DRUG DOSE; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY;

DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; FIBROMYALGIA; HUMANS; KETAMINE; LIMBIC SYSTEM; NOCICEPTORS; RECEPTORS, DOPAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 33747873033     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2006.01.457     Document Type: Article

References (40)

1. Altier N., and Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65 (1999) 2269-2287
2. Burkey A.R., Carstens E., and Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 19 (1999) 4169-4179
3. Clauw D.J. FibromyalgiaMore than just a musculoskeletal disease. Am Fam Physician 52 (1995) 843-854
4. Clauw D.J., and Crofford L.J. Chronic widespread pain and fibromyalgia. What we know, and what we need to know. Best Pract Res Clin Rheumatol 17 (2003) 685-701
5. Decina P., Mukherjee S., Caracci G., and Harrison K. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes. Am J Psychiatry 149 (1992) 1075-1080
6. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer I., Goldman D., Xu K., Shabalina S.A., Shagin D., Max M.B., Makarov S.S., and Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14 (2005) 135-143
7. Ford B. Pain in Parkinson's disease. Clin Neurosci 5 (1998) 63-72
8. Gao X., Zhang Y., and Wu G. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats. Eur J Pharmacol 418 (2001) 73-77
9. Goetz C.G., Tanner C.M., Levy M., Wilson R.S., and Garron D.C. Pain in Parkinson's disease. Mov Disord 1 (1986) 45-49
10. Graven-Nielsen T., Aspegren Kendall S., Henriksson K.G., Bengtsson M., Sorensen J., Johnson A., Gerdle B., and Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85 (2000) 483-491
11. Hocking G., and Cousins M.J. Ketamine in chronic pain management. An evidence-based review. Anesth Analg 97 (2003) 1730-1739
12. Hollon T.R., Bek M.J., Lachowicz J.E., Ariano M.A., Mezey E., Ramachandran R., Wersinger S.R., Soares-da-Silva P., Liu Z.F., Grinberg A., Drago J., Young III W.S., Westphal H., Jose P.A., and Sibley D.R. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22 (2002) 10801-10810
13. Holman A.J., and Meyers R.R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52 (2005) 2495-2505
14. Hudson J.I., Goldenberg D.L., Pope Jr. H.G., Keck Jr. P.E., and Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92 (1992) 363-367
15. Jain A.K., Carruthers B.M., van de Sande M.I., Barron S.R., Donaldson C.C.S., Dunne J.V., Gingrich E., Heffez D.S., Leung F.Y., Malone D.G., Romano T.J., Russell I.J., Saul D., and Seibel D.G. Fibromyalgia syndrome. Canadian clinical working case definition, diagnostic and treatment protocols-a consensus document. J Musculoskeletal Pain 11 (2004) 3-107
16. Jost W.H. Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 250 Suppl I (2003) I28-I30
17. Jost W.H., and Eckardt V.F. Constipation in idiopathic Parkinson's disease. Scand J Gastroenterol 38 (2003) 681-686
18. Larsen J.P. Sleep disorders in Parkinson's disease. Adv Neurol 91 (2003) 329-334
19. Lauterbach E.C. The neuropsychiatry of Parkinson's disease and related disorders. Psychiatr Clin North Am 27 (2004) 801-825
20. Leriche L., Schwartz J.C., and Sokoloff P. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology 45 (2003) 174-181
21. Lopez-Avila A., Coffeen U., Ortega-Legaspi J.M., del Angel R., and Pellicer F. Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain 111 (2004) 136-143
22. Martinez-Lavin M., Hermosillo A.G., Rosas M., and Soto M.E. Circadian studies of autonomic nervous balance in patients with fibromyalgia. A heart rate variability analysis. Arthritis Rheum 41 (1998) 1966-1971
23. Pani L., Porcella A., and Gessa G.L. The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry 5 (2000) 14-21
24. Poewe W., and Hogl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 63 Suppl 3 (2004) S12-S16
25. Rabben T., Skjelbred P., and Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 289 (1999) 1060-1066
26. Saade N.E., Atweh S.F., Bahuth N.B., and Jabbur S.J. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res 751 (1997) 1-12
27. Seeman P., Ko F., and Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10 (2005) 877-883
28. Singer C. Urinary dysfunction in Parkinson's disease. Clin Neurosci 5 (1998) 78-86
29. Sotres-Bayon F., Torres-Lopez E., Lopez-Avila A., del Angel R., and Pellicer F. Lesion and electrical stimulation of the ventral tegmental area modify persistent nociceptive behavior in the rat. Brain Res 898 (2001) 342-349
30. Staud R., Vierck C.J., Cannon R.L., Mauderli A.P., and Price D.D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91 (2001) 165-175
31. Staud R., Vierck C.J., Robinson M.E., and Price D.D. Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain 6 (2005) 323-332
32. Takeda R., Ikeda T., Tsuda F., Abe H., Hashiguchi H., Ishida Y., and Nishimori T. Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation. Neurosci Res 52 (2005) 31-36
33. Wang X., Zhong P., Gu Z., and Yan Z. Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci 23 (2003) 9852-9861
34. Willis W.D. Long-term potentiation in spinothalamic neurons. Brain Res Brain Res Rev 40 (2002) 202-214
35. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., Fam A.G., Farber S.J., Fiechtner J.J., Franklin C.M., Gatter R.A., Hamaty D., Lessard J., Lichtbroun A.S., Masi A.T., McCain G.A., Reynolds W.J., Romano T.J., Russell I.J., and Sheon R.P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
36. Wolfe F., Ross K., Anderson J., Russell I.J., and Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
37. Wood P.B. Stress and dopamine. Implications for the pathophysiology of chronic widespread pain. Med Hypotheses 62 (2004) 420-424
38. Woolf C.J., and Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation. Implications for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991) 293-299
39. Yunus M.B., and Aldag J.C. Restless legs syndrome and leg cramps in fibromyalgia syndrome. A controlled study. BMJ 312 (1996) 1339
40. Zweig R.M. Sensory symptoms. In: Factor S.A., and Weiner W.J. (Eds). Parkinson's Disease. Diagnosis and Clinical Management (2002), Demos Medical Publishing, New York, NY 67-74